Hepatitis C: State of Medicaid Access
Hepatitis C: State of Medicaid Access provides an in-depth evaluation of direct-acting antiviral (DAA) access for hepatitis C treatment in state Medicaid programs.
Hep ElimiNATION is an advocacy tool to bring awareness to policymakers, public health agencies, and communities about a broad range of key considerations for elimination.
Hepatitis Network for Education and Testing (HepNET)
HepNET is a network focused on identifying and addressing the unmet needs of people who inject drugs to improve their access to viral hepatitis care.
#Voices4Hep is a network of patient, provider, and community advocates taking action in their communities to eliminate viral hepatitis.
NVHR is working to lead the viral hepatitis community in elimination advocacy efforts and to eliminate viral hepatitis in the United States by 2030.
NVHR aims to support a comprehensive and integrated response to viral hepatitis in the United States by advocating for fully funded state and federal elimination plans.
NVHR is working to ensure integration and alignment of viral hepatitis elimination strategies into comprehensive drug user health initiatives across harm reduction, treatment, and recovery.
NVHR is fighting for equitable access to viral hepatitis prevention and care to effectively serve disproportionately impacted populations.
NVHR is working to raise awareness about, improve access to and increase utilization of hepatitis A and hepatitis B vaccines.
NVHR is working to ensure that U.S. Preventive Services Task Force (USPSTF) guidelines for hepatitis B and C testing are implemented in public and private healthcare systems.
Demystifying Drug Development: From Molecule to Medicine
NVHR and Treatment Action Group (TAG) discuss what it will take to make rapid HCV diagnostics a reality in the United States. Dr. Anne Gaynor from the Association of Public Health Laboratories (APHL) walks us through the FDA announcement to reclassify HCV diagnostics.